Colleran David (CIK 1646558) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-17). Recent activity: Buy ANIK (9,388 shares), Buy ANIK (4,694 shares), Sell ANIK (4,168 shares), Buy ANIK (6,449 shares), Sell ANIK (1,893 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-17 | Anika Therapeutics, Inc. (ANIK) | EVP, General Counsel, Corp Sec | Buy | 9,388 | $0 |
| 2026-03-17 | Anika Therapeutics, Inc. (ANIK) | EVP, General Counsel, Corp Sec | Buy | 4,694 | $0 |
| 2026-03-17 | Anika Therapeutics, Inc. (ANIK) | EVP, General Counsel, Corp Sec | Sell | 4,168 | $59,186 |
| 2026-03-17 | Anika Therapeutics, Inc. (ANIK) | EVP, General Counsel, Corp Sec | Buy | 6,449 | $0 |
| 2026-03-17 | Anika Therapeutics, Inc. (ANIK) | EVP, General Counsel, Corp Sec | Sell | 1,893 | $26,881 |
| 2026-03-11 | Anika Therapeutics, Inc. (ANIK) | EVP, General Counsel, Corp Sec | Buy | 5,465 | $0 |
| 2026-03-11 | Anika Therapeutics, Inc. (ANIK) | EVP, General Counsel, Corp Sec | Sell | 1,919 | $28,708 |
来源：SEC Form 4 申报文件 · 截至 2026-03-17